Riskpilot← Back to searchSign inGet full accessInoris Medical AB
ABActiveOrg 5565842712Amerikavägen 42Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20001 employees
Revenue 2024
SEK 136K
+13% vs 2023
EBITDA margin
—
Equity ratio
41.1%
Financial strength
Net profit 2024
SEK -21K
-162% vs 2023
| Revenue | SEK 136K | +13% |
| EBITDA | — | — |
| Net profit | SEK -21K | -162% |
| Total assets | SEK 1,8M | -6% |
| Equity | SEK 755K | -3% |
| Employees | 1 | — |
Legal name
Inoris Medical AB
Org number
5565842712
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
27 januari 2000
Share capital
SEK 140 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva utveckling, tillverkning, inköp och försäljning av medicinska produkter, förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Amerikavägen 42
Email
jan@jcform.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 243 | 196 | 150 | 120 | 136 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 82 | −33 | −38 | 13 | — |
| Depreciation & amort. | −22 | −22 | −22 | −22 | −22 |
| EBIT | 60 | −55 | −60 | −9 | −22 |
| Net financials | — | — | — | 1 | 1 |
| Profit before tax | 60 | −55 | −60 | −8 | −21 |
| Tax | −11 | −0 | −0 | −0 | −0 |
| Net profit | 49 | −55 | −60 | −8 | −21 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 018 | 1 876 | 1 944 | 1 952 | 1 836 |
| Equity | 899 | 844 | 784 | 776 | 755 |
| Long-term debt | 1 119 | 1 031 | 1 160 | 1 160 | 1 070 |
| Short-term debt | 0 | 0 | 0 | 16 | 11 |
| Total debt | 1 119 | 1 031 | 1 160 | 1 176 | 1 081 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
41.1%
This company
38.2%
Market median
+8% vs market
20202024
Return on equity
-2.8%
This company
18.4%
Market median
-115% vs market
20202024
Net profit margin
-15.4%
This company
8.1%
Market median
-290% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
1.43×
This company
0.62×
Market median
-131% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JC Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
EK Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Inoris Medical AB (this company)
INORIS MEDICAL SP ZO.OInoris Medical Sp Zo.oBoard members of Inoris Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Kristina Kantoft | Chief Auditor | 0 companies |
| Jan Cyganik | Chief Executive Officer | 0 companies |
| Tadeusz Jozef Tyszkiewicz | Chairman | 0 companies |
| Torsten Sigvard Bengtsson | Board of Directors | 0 companies |